These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 20061007)

  • 1. Immune responses to malignancies.
    Whiteside TL
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S272-83. PubMed ID: 20061007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 22. Immune responses to malignancies.
    Whiteside TL
    J Allergy Clin Immunol; 2003 Feb; 111(2 Suppl):S677-86. PubMed ID: 12592313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of cancer: reprogramming tumor-immune crosstalk.
    Payne KK; Toor AA; Wang XY; Manjili MH
    Clin Dev Immunol; 2012; 2012():760965. PubMed ID: 23097673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting unique tumor antigens and modulating the cytokine environment may improve immunotherapy for tumors with immune escape mechanisms.
    Slingluff CL
    Cancer Immunol Immunother; 1999 Oct; 48(7):371-3. PubMed ID: 10501849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling defects in anti-tumor T cells.
    Frey AB; Monu N
    Immunol Rev; 2008 Apr; 222():192-205. PubMed ID: 18364003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting inhibitory pathways in cancer immunotherapy.
    Lasaro MO; Ertl HC
    Curr Opin Immunol; 2010 Jun; 22(3):385-90. PubMed ID: 20466529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
    Finn OJ
    Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
    Mapara MY; Sykes M
    J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?
    Pawelec G
    Cancer Immunol Immunother; 1999 Oct; 48(7):343-5. PubMed ID: 10501845
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in personalized neoantigen vaccines for cancer immunotherapy.
    Sun C; Xu S
    Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor immunity and cellular cancer therapies].
    Catros-Quemener V; Bouet F; Genetet N
    Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
    Fu C; Jiang A
    Front Immunol; 2018; 9():3059. PubMed ID: 30619378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L; Carbone DP
    Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor resistance to CD8+ T cell-based therapeutic vaccination.
    Huang Y; Shah S; Qiao L
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):205-17. PubMed ID: 17659376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current challenges for cancer vaccine adjuvant development.
    Bowen WS; Svrivastava AK; Batra L; Barsoumian H; Shirwan H
    Expert Rev Vaccines; 2018 Mar; 17(3):207-215. PubMed ID: 29372660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.
    Butt AQ; Mills KH
    Oncogene; 2014 Sep; 33(38):4623-31. PubMed ID: 24141774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.